Trials / Unknown
UnknownNCT03409835
Effect of Ramosetron on Post-discharge Nausea and Vomiting
Effect of Ramosetron on Post-discharge Nausea and Vomiting in Patients Undergoing Gynecologic Surgery Through a Day-surgery Center
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 100 (estimated)
- Sponsor
- Seoul National University Bundang Hospital · Academic / Other
- Sex
- Female
- Age
- 20 Years – 60 Years
- Healthy volunteers
- Not accepted
Summary
Nausea and vomiting after general anesthesia is one of the common anesthetic complications. If the patient is discharged from the hospital after surgery, proper treatment may be delayed or impossible if nausea or vomiting occurs. Thus, It is necessary to prevent these symptoms beforehand. Patients who underwent gynecologic surgery will be treated with prophylactic ramosetron to determine whether the frequency of nausea and vomiting is decreased when the patient returned home after discharge.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Ramosetron | Ramosetron 0.3 mg is administered after induction of general anesthesia. |
| DRUG | Normal saline | Normal saline 2 ml is administered after induction of general anesthesia. |
Timeline
- Start date
- 2018-03-01
- Primary completion
- 2019-02-01
- Completion
- 2019-06-01
- First posted
- 2018-01-24
- Last updated
- 2018-04-20
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT03409835. Inclusion in this directory is not an endorsement.